A third dose of the Pfizer/BioNTech COVID-19 vaccine can "strongly" boost protection against the delta variant -- beyond the protection afforded by the standard two doses, suggests new data released ...
NEW YORK (WABC) -- Pfizer is asking the FDA to amend its COVID-19 vaccine booster authorization to include all adults 18 and older. In September, the FDA and CDC authorized Pfizer booster shots after ...
The group will discus and vote on whether to recommend Pfizer booster shots. The Food and Drug Administration's independent advisory committee will convene in open session Friday to review the latest ...
Health experts are reinforcing the point that full vaccination remains highly effective against severe illness and death caused by COVID-19 as federal regulators consider the possibility of ...
12don MSN
Comparing COVID-19 vaccines
A recent study has provided the first side-by-side comparison of how three major COVID-19 vaccine types differ in triggering ...
WASHINGTON — U.S. regulators approved updated COVID-19 shots Wednesday but limited their use for many Americans — and removed one of the two vaccines available for young children. The new shots from ...
Pfizer's CEO confirmed on Twitter that they seek emergency use authorization to provide a second COVID-19 booster shot for adults 65 years and older. Albert Bourla said that they submitted the ...
Pfizer Inc and its German partner BioNTech on Monday sought the U.S. Food and Drug Administration's authorization for an ...
Pfizer and BioNTech said Wednesday that initial lab tests show that the omicron variant partly escapes protection offered by the companies' two-dose regimen of their COVID-19 vaccine. However, those ...
Pfizer CEO Albert Bourla appeared on ABC's "This Week." Pfizer CEO Albert Bourla said on ABC's "This Week" Sunday it's possible to provide both COVID-19 booster shots as well as doses for people who ...
The Food and Drug Administration is investigating whether Covid-19 vaccines caused deaths in adults, as part of a safety ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results